RedHill Biopharma (Israel) Financial Diagnostics

RDHL -- Israel Stock  

ILS 260.10  0.90  0.34%

RedHill Biopharma Ltd diagnostics interface makes it easy to digest most current publicly released information about RedHill Biopharma as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis RedHill Biopharma price relationship with some important fundamental indicators such as market cap and management efficiency.

RedHill Biopharma Note

The company recorded loss per share of 0.19. RedHill Biopharma Ltd had not issued any dividends in recent years. RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late clinical-stage drugs for the treatment of gastrointestinal diseases. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 74 people. To find out more about REDHILL BIOPHARMA contact Ori Shilo at 972 3 541 3131 or learn more at

RedHill Biopharma Alerts

RedHill Biopharma generates negative expected return over the last 30 days
RedHill Biopharma has high historical volatility and very poor performance
The company reported revenue of 9M. Net Loss for the year was (41.55M) with profit before overhead, payroll, taxes, and interest of 1.88M.
REDHILL BIOPHARMA has accumulated about 43.03M in cash with (40.43M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 765.32M.

Management Efficiency

RedHill Biopharma Ltd has return on total asset (ROA) of (51.61) % which means that it has lost $51.61 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (112.59) % meaning that it generated substantial loss on money invested by shareholders.

Technical Drivers

RedHill Biopharma Ltd holds Coefficient Of Variation of 8309.04, Semi Deviation of 4.02 and Risk Adjusted Performance of 0.0233. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of RedHill Biopharma as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for RedHill Biopharma which can be compared to its competitors. Please check RedHill Biopharma Downside Deviation, Standard Deviation, Information Ratio, as well as the relationship between Coefficient Of Variation and Variance to decide if RedHill Biopharma is priced some-what accurately providing market reflects its current price of 260.1 per share.

RedHill Biopharma Price Movement Analysis

Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. RedHill Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for RedHill Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

RedHill Biopharma Technical and Predictive Indicators

RedHill Biopharma Forecast Models

Did you try this?

Run Fundamentals Comparison Now


Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Fundamentals Comparison

Also Currentnly Active

Purchased over 50 shares of
a day ago
Traded for 56.845
Purchased over 20 shares of
a day ago
Traded for 141.97
Purchased over 50 shares of
a day ago
Traded for 56.845
Additionally take a look at Your Equity Center. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.